Literature DB >> 11203463

The nuclear export signal within the adenovirus E4orf6 protein contributes to several steps in the viral life cycle.

E Bridge.   

Abstract

Mesh:

Substances:

Year:  2000        PMID: 11203463      PMCID: PMC112487          DOI: 10.1128/jvi.74.24.12000-12001.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


× No keyword cloud information.
  6 in total

1.  Adenovirus late gene expression does not require a Rev-like nuclear RNA export pathway.

Authors:  C Rabino; A Aspegren; K Corbin-Lickfett; E Bridge
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  Nuclear export of the E1B 55-kDa and E4 34-kDa adenoviral oncoproteins mediated by a rev-like signal sequence.

Authors:  M Dobbelstein; J Roth; W T Kimberly; A J Levine; T Shenk
Journal:  EMBO J       Date:  1997-07-16       Impact factor: 11.598

3.  CRM1 is an export receptor for leucine-rich nuclear export signals.

Authors:  M Fornerod; M Ohno; M Yoshida; I W Mattaj
Journal:  Cell       Date:  1997-09-19       Impact factor: 41.582

4.  The nuclear export signal within the E4orf6 protein of adenovirus type 5 supports virus replication and cytoplasmic accumulation of viral mRNA.

Authors:  S Weigel; M Dobbelstein
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

5.  Adenovirus type 5 E4orf3 protein relieves p53 inhibition by E1B-55-kilodalton protein.

Authors:  C König; J Roth; M Dobbelstein
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

6.  Analysis of adenovirus early region 4-encoded polypeptides synthesized in productively infected cells.

Authors:  J R Cutt; T Shenk; P Hearing
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

  6 in total
  1 in total

1.  E4orf6 variants with separate abilities to augment adenovirus replication and direct nuclear localization of the E1B 55-kilodalton protein.

Authors:  Joseph S Orlando; David A Ornelles
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.